Literature DB >> 6790848

Hyperornithinaemia associated with gyrate atrophy of the choroid and retina: in vivo and in vitro response to vitamin B6.

K Tada, T Saito, K Omura, S Hayasaka, K Mizuno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790848     DOI: 10.1007/BF02263591

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

1.  STUDIES ON ORNITHINE-KETOACID TRANSAMINASE. I. PURIFICATION AND PROPERTIES.

Authors:  N KATUNUMA; Y MATSUDA; I TOMINO
Journal:  J Biochem       Date:  1964-12       Impact factor: 3.387

2.  Increased sensitivity of lymphocyte delta1-pyrroline-5-carboxylate reductase to inhibition by proline with transformation.

Authors:  D Valle; R M Blaese; J M Phang
Journal:  Nature       Date:  1975-01-17       Impact factor: 49.962

3.  Raised plasma-ornithine and gyrate atrophy of the choroid and retina.

Authors:  O Simell; K Takki
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

4.  Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.

Authors:  K Takki
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

5.  A radioisotopic assay for ornithine-delta-transaminase.

Authors:  J M Phang; S J Downing; D Valle
Journal:  Anal Biochem       Date:  1973-09       Impact factor: 3.365

6.  Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine.

Authors:  E L Berson; S Y Schmidt; A R Rabin
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

7.  Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina.

Authors:  V E Shih; E L Berson; R Mandell; S Y Schmidt
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

  7 in total
  1 in total

1.  Biochemical and therapeutical studies in a case of atrophia gyrata.

Authors:  W Behrens-Baumann; U König; K Schröder; I Hansmann; U Langenbeck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.